Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Best Practices in Fragile X Syndrome Treatment Development.
Erickson CA, Kaufmann WE, Budimirovic DB, Lachiewicz A, Haas-Givler B, Miller RM, Weber JD, Abbeduto L, Hessl D, Hagerman RJ, Berry-Kravis E. Erickson CA, et al. Among authors: budimirovic db. Brain Sci. 2018 Dec 15;8(12):224. doi: 10.3390/brainsci8120224. Brain Sci. 2018. PMID: 30558274 Free PMC article.
Peculiarities in the gestural repertoire: an early marker for Rett syndrome?
Marschik PB, Sigafoos J, Kaufmann WE, Wolin T, Talisa VB, Bartl-Pokorny KD, Budimirovic DB, Vollmann R, Einspieler C. Marschik PB, et al. Among authors: budimirovic db. Res Dev Disabil. 2012 Nov-Dec;33(6):1715-21. doi: 10.1016/j.ridd.2012.05.014. Epub 2012 Jun 13. Res Dev Disabil. 2012. PMID: 22699245 Free PMC article.
Genomic studies in fragile X premutation carriers.
Lozano R, Hagerman RJ, Duyzend M, Budimirovic DB, Eichler EE, Tassone F. Lozano R, et al. Among authors: budimirovic db. J Neurodev Disord. 2014;6(1):27. doi: 10.1186/1866-1955-6-27. Epub 2014 Jul 30. J Neurodev Disord. 2014. PMID: 25170347 Free PMC article.
Arbaclofen in fragile X syndrome: results of phase 3 trials.
Berry-Kravis E, Hagerman R, Visootsak J, Budimirovic D, Kaufmann WE, Cherubini M, Zarevics P, Walton-Bowen K, Wang P, Bear MF, Carpenter RL. Berry-Kravis E, et al. J Neurodev Disord. 2017 Jun 12;9:3. doi: 10.1186/s11689-016-9181-6. eCollection 2017. J Neurodev Disord. 2017. PMID: 28616094 Free PMC article.
Fragile X targeted pharmacotherapy: lessons learned and future directions.
Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, Fitzpatrick SE, Brown WT, Budimirovic D, Hagerman RJ, Hessl D, Kaufmann WE, Berry-Kravis E. Erickson CA, et al. J Neurodev Disord. 2017 Jun 12;9:7. doi: 10.1186/s11689-017-9186-9. eCollection 2017. J Neurodev Disord. 2017. PMID: 28616096 Free PMC article. Review.
37 results